1 / 29

Pediatric Adherence

2. Learning Objectives. Identify ways to prepare a family for ARV adherence List ways to monitor and support ARV adherenceDescribe ways to assess adherence . 3. Adherence to Treatment: Issues for Children. ARV treatment for children requires:Collaboration between the child and caregiver(s)Co

tuvya
Télécharger la présentation

Pediatric Adherence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Pediatric Adherence Step 9: Pediatric Adherence (Slides 247 275) 60 minutes Step 9: Pediatric Adherence (Slides 247 275) 60 minutes

    2. 2 Learning Objectives Identify ways to prepare a family for ARV adherence List ways to monitor and support ARV adherence Describe ways to assess adherence

    3. 3 Adherence to Treatment: Issues for Children ARV treatment for children requires: Collaboration between the child and caregiver(s) Commitment of the caregiver(s) Cooperation of the child ARV treatment for children is complicated by: Developmental stage/age of the child Parent-child interaction Psychosocial milieu Relatively poor palatability of many pediatric formulations Caregiver factors We would like to begin to consider ways that an approach to adherence in children may differ from adherence in adults. You cannot simply hand the pills over to a baby and suggest they take them twice daily. It is a touch more complicated, primarily in the ways noted in this slide. The next several slides review some adherence data on children with HIV. These are European and US studies the specific ARVs used may not be relevant in your clinic - but the issue of adherence is critically important in both resource rich and resource limited settings. We would like to begin to consider ways that an approach to adherence in children may differ from adherence in adults. You cannot simply hand the pills over to a baby and suggest they take them twice daily. It is a touch more complicated, primarily in the ways noted in this slide. The next several slides review some adherence data on children with HIV. These are European and US studies the specific ARVs used may not be relevant in your clinic - but the issue of adherence is critically important in both resource rich and resource limited settings.

    4. 4 Reported Difficulties Taking ARV Medications, PENTA 5 Taste/Palatability/Volume Difficulties with unpleasant flavor and/or smell Nausea Too many pills Social Situations Fear of disclosure Visiting or out with friends Visiting relatives over weekend Visitors in house Had to leave child with a friend for the day

More Related